Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03954457 · ClinicalTrials.gov registry record · NA
Social Ecology and the Prevention of Suicide and Aggression in African American Youth
A NA study of Suicide and Aggression, sponsored by DePaul University.
- Completed
- Registry status
- NA
- Development phase
- 939
- Enrollment target
- 1
- Study location
NCT03954457: Completed NA study of Suicide and Aggression, sponsored by DePaul University.
NCT03954457 is a NA study of Suicide and Aggression that has completed, run by DePaul University. The registered enrollment target is 939 participants, below the 6,980-participant average among 92 other Suicide trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03954457, a NA study of Suicide and Aggression, has completed, sponsored by DePaul University.
- COMPLETED
- Registry status
- NA
- Development phase
- 939 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the efficacy of a culturally-grounded, school-based suicide and aggression preventive intervention for African American adolescents (Adapted-Coping with Stress Course \[A-CWS\]). The A-CWS is a 15-session, cognitive-behavioral group intervention designed to develop and enhance African American youths' skills for coping with stress. Emphasis is given to the identification of stress unique to the day-to-day experiences of the youths and options for reducing stress that are culturally consistent. A total of four public high schools in a large Midwestern metropolitan area participated in this study that used a randomized-controlled design, with randomization occurring at the individual level. Participants were randomized either to the A-CWS intervention condition, or to a standard care control condition. This study had three hypotheses: (1) The intervention would raise adaptive coping, relative to the standard care control condition; (2) coping skills would explain the effects of the A-CWS intervention on problematic outcomes (i.e., suicidality, aggression); and (3) socio-ecological factors (i.e., neighborhood and family characteristics) would influence the effect of the A-CWS intervention on coping skills, and the effect of coping skills on problematic outcomes.
Primary Outcome
Suicide ideation was measured with the Center for Epidemiological Studies - Depression (CES-D) Appended Suicide Measure, a 4-item self-report inventory that assesses suicide ideation during the last week.
Conditions Studied
Interventions
- BEHAVIORAL Standard Care Control
- BEHAVIORAL A-CWS
Study Locations (1)
Illinois
- DePaul University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 939 participants |
| Start Date | 2013-02-05 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
What the finished NCT03954457 record still lists
NCT03954457 is an interventional study that assigns participants to a tested intervention. The registered 939 participants enrollment target is mid-sized for trials with a published cap, below the 6,980-participant average among 92 other Suicide trials with a reported enrollment target (87% lower).
The record links to 2 conditions, with Suicide appearing as the primary indexed condition, and to 2 interventions - of which Standard Care Control is the first listed.
NCT03954457 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT03954457 about?
NCT03954457 is a clinical study titled "Social Ecology and the Prevention of Suicide and Aggression in African American Youth". The purpose of this study is to examine the efficacy of a culturally-grounded, school-based suicide and aggression preventive intervention for African American adolescents (Adapted-Coping with Stress Course \[A-CWS\]). The A-CWS is a 15-session, cognitive-behavioral group intervention designed to de...
What is the current status of trial NCT03954457?
This trial is currently completed. It is a NA study. The enrollment target is 939 participants. The study started on 2013-02-05. Estimated completion is 2020-07-31.
What conditions does trial NCT03954457 study?
This clinical trial studies the following conditions: Suicide, Aggression.
What interventions are being tested in trial NCT03954457?
The interventions under investigation include: Standard Care Control (BEHAVIORAL), A-CWS (BEHAVIORAL).
Who is sponsoring clinical trial NCT03954457?
This trial is sponsored by DePaul University, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03954457 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Suicide
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03954457's enrollment target sits among peer trials
939 14th of 92 higher than 79 of 92 other Suicide trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Randomized Clinical Trial of Supplementing Brief Psychotherapy With a Mobile App
RECRUITING · NA
-
Reducing Suicide Risk Among Aging Caregivers of Persons With AD/ADRD
RECRUITING · NA
-
Functional Connectivity Alterations in Suicidal Patients Among Opioid Users
RECRUITING · NA
-
Suicide Specific Rumination in Veterans
RECRUITING · NA
-
Real-time Examination of Skills and Coping Use in Teen's Everyday Lives
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03075696 · 940 participants · Phase 1
A Dose Escalation Study of Glofitamab (RO7082859) as a Single Agent and in Combination With Obinutuzumab, Administered After a Fixed, Single Pre-treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-cell Non-hodgkin's Lymphoma
- NCT06855277 · 940 participants · Phase 3
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- NCT06808334 · 942 participants
CLAiR Pivotal Study
- NCT07190209 · 942 participants · Phase 3
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI